Drugmakers Clinch Deals to Boost Supplies of Pfizer’s Covid Pill

Bloomberg2022-03-17

About three dozen drugmakers will produce low-cost versions of Pfizer Inc.’s Covid-19 pill as part of an effort to expand supplies of the highly effective drug in lower-income regions.Those companies,...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
4